Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(64 sites)
United States
Research Site, Boston, Massachusetts Research Site, Hackensack, New Jersey Research Site, New Brunswick, New Jersey Research Site, New York, New York Research Site, New York, New York Research Site, Charlotte, North Carolina Research Site, Charlotte, North Carolina Research Site, Columbus, Ohio Research Site, Portland, Oregon Research Site, Philadelphia, Pennsylvania Research Site, Pittsburgh, Pennsylvania Research Site, Providence, Rhode Island Research Site, Houston, Texas Australia
Research Site, Heidelberg Czechia
Research Site, Ostrava - Poruba Research Site, Praha 2 - Nové Město Denmark
Research Site, Copenhagen France
Research Site, Clermont-Ferrand Research Site, Montpellier Research Site, Saint-Cloud Spain
Research Site, Palma de Mallorca Research Site, Santiago de Compostela Taiwan
Research Site, Kaohsiung City United Kingdom
Research Site, Southampton